5. Production begins hemocytoblast –
multipotent stem cell
Control step - proerythroblast
Cell near the end of development ejects
nucleus and becomes a reticulocyte
Develop into mature RBC within 1-2 days
Negative feedback balances production with
destruction
Controlled condition is amount of oxygen
delivery to tissues
Hypoxia stimulates release of erythropoietin –
promote maturation
9. Functions of Erythrocytes
Gas transport & exchange
Primary function
O2
CO2
pH control of blood
Hemostasis
10. Structure
Biconcave shape
Greater surface area for gas exchange
Increase flexibility – squeeze through capillaries
Rigid but flexible cytoskeleton
Increase flexibility
Mature erythrocytes has no nucleus, Golgi apparatus and
mitochondria
Glycolysis for ATP production
no O2 consumption during transportation
11.
12. Haemoglobin
Main oxygen transporter
Hemoglobin is a protein
Hemoglobin = haem + globin
Globin - protein
Haem
Iron + Protoporphyrin IX
14. Iron
Ferrous form (Fe2+).
Iron attached to nitrogen atom
of each pyrrole ring.
Iron can bind with
Oxygen
Carbon monoxide.
15. Globin
Made-up of 4 polypeptide chains
2 alpha like chains
2 beta like chains
Each polypeptide chain has one
bound haeme molecule
1 Globin molecule has 4 haeme
molecules
Can bind 4 oxygen molecules
16. Haemoglobin Production
In the early stages of erythrocyte maturation
Nucleus, Ribosomes, Golgi apparatus & mitochondria are present
Nucleus – code for globin chains
Mitochondria - aerobic generation of energy - insertion of
ferrous iron into protoporphyrin IX – haem production
Ribosomes - globin and other protein synthesis
20. O2 binding to hemoglobin
Oxygen binds reversibly to Hb
Upon O2 binding to an active site of hemoglobin there is a
conformational change in the Hb molecule
‘Cooperation’ - binding of oxygen to one site of the four subunits will
increase the likelihood of the remaining sites to bind with oxygen as well.
21. O2 binding to haemoglobin
Allostery
Regulation of an enzyme by binding an effector molecule at
a site other than the enzyme's active site
Allosteric effectors
H+
CO2
2,3-bisphosphoglycerate
22. Allosteric effect & cooperative effect– Hemoglobin vs
Myoglobin
Exponential vs sigmoid curve
Cooperativity Enhances Oxygen
Delivery by Hemoglobin.
cooperativity between O2-binding
sites, hemoglobin delivers more
O2 to tissues than would a
noncooperative protein (about
1.7x)
23. Effect of 2,3 - BPG
2,3-biphosphoglycerate – by product of glycolysis
Binds the central cavity of the Hb molecule only when its in the
tensed state (low affinity state)
increase stability of T-state
Therefor decrease oxygen affinity – increases oxygen release at
tissues
24. Effect of CO2 & pH
Bohr effect
Increases in the carbon dioxide partial pressure of blood or decreases in
blood pH result in a lower affinity of hemoglobin for oxygen
Carbaminohemoglobin & H+ stabilizes T state hemoglobin by
formation of ion pairs.
Allows unloading of oxygen in peripheral tissues
⇌
CO2 + H2O H2CO3 H+ + HCO3
−
⇌
CO2 + Haemoglobin ⇌ Carbaminohemoglobin
30. Basic pathogenesis – HbS polymerization
First disease to demonstrate genetic mutation
can lead to production of abnormal protein.
“First molecular disease”
Mutation substituting thymine for adenine in
the sixth codon of the beta-chain gene
GAG to GTG
Coding of valine instead of glutamate in
position 6 of the Hb beta chain
glutamic acid - hydrophilic
Valine – hydrophobic
Formation of hydrophobic patch on the Hb
molecule
31. When Hb is in tensed state - another
hydrophobic pocket is exposed
In both normal Hb and HbS
Formed by ßPhe85 and ßLeu88
In tensed state (deoxygenated)
Normal Hb -> no hydrophobic patch -> no
polymerization
HbS - > polymerization
32. Polymerization -> helical fiber formation
Polymerization is the root cause for pathogenesis
Fibers group together
stiffen the red cell
repeated and prolonged sickling involves the membrane
give rise to the characteristic shape - Sickle
34. Oxygen saturation
Decreased SpO2 increase the likelihood of sickling
High altitudes
Diseased pulmonary vascular bed - frequent infarcts and lung infections
High O2 consumption – exercise, fever, acidosis
Maximum polymerization at 0% saturation
2,3-BPG, low pH & temp, increased CO2 -> stabilize T state -> increase
sickling
35. Intracellular Hb composition
Presence of other hemoglobin types reduce the chances polymerization
Reduce with the concentration
HbF > HbA2> HbA > HbC
Disperse among HbS -> reduce contact
36.
37. Intracellular Hb concentration
Higher haemoglobin concentrations increase polymerized Hb
concentration
Therefor increase number of sickled cells
38. Intracellular Hb concentration
Repeated sickling -> Membrane damage -> activation of ion channels ->
Dysregulation of cation homeostasis
K-Cl co-transport system
Ca-dependent K-channel (Gardos channel)
Loss of intracellular K+ -> cellular dehydration
Increase in intracellular Hb concentration -> increase chances of sickling
39.
40. Basic pathogenesis - Erythrocytic membrane
changes
Methemoglobin formation
Fe 2+ -> Fe3+
Denaturing of Hb -> hemichromes
Oxidative stress - > membrane alterations
The normal asymmetry of membrane phospholipids is
disrupted (reversal)
Promote coagulation
Proteins of the cytoskeleton express outside
Sp. protein band 3 (Band 3 anion transport protein)
Anti-band 3 IgGs accumulate on the protein band 3
aggregates, inducing erythrophagocytosis by
macrophages
Membrane changes cause microparticle formation ->
cell membrane loss
Leads to stiffening and increased fragility of the SS-
RBCs
41. After recurrent episodes of sickling
membrane damage occurs
cells are no longer capable of resuming the biconcave shape upon
reoxygenation.
irreversibly sickled cells (ISCs).
Cause vaso-occlusion
5-50% of RBCs permanently remain in the sickled shape
Membrane alterations -> trap in RES -> extravascular hemolysis - >
anemia
42. Is sickling the only cause of
vaso-occlusion
“Delay time” – time gap between trigger event
& sickling of red cells
If there is a marked delay time – red cells can
escape microvasculature before starts sickling
If the delay time is shorter than the transit time -
> vaso-occlusion
Current data suggest that delay time is
actually longer than the transit time
Therefore, the passage must be delayed by
other causes which contribute to the
development of sickling within the
microvessels.
43. Mechanisms Participating In the
Vaso-occlusive Event
Retardation of the blood flow through the microcirculation
Adhesion of young red cells on the endothelial wall
Activation of the endothelial cells
Activation of the passing-by leucocytes and platelets and adhesion on the
endothelial wall
Vasoconstriction
44. Increased adhesion of sickle red blood
cells to the endothelium
Due to haemolysis -> decresed Hb -> increased reticulocyte
production
“Stress reticulocytes”
Coming out prematurely from the bone marrow because of the
anemic stress
Express adhesion proteins that normally keep them in the
marrow
Stress reticulocytes bind to the endothelium of post-capillary
venules
Slow down the blood flow mature SS-RBCs kept a longer time
in a hypoxic environment.
Entrapment of irreversible sickle cells and to the complete
occlusion of the micro-vessels
47. Activation of the leucocytes and
platelets
Adherent leukocytes in post-capillary venules - major factor causing circulatory slowing
down that initiates VOCs.
Activators
SS-RBCs are capable of abnormally interacting PMNs.
Creation of a proinflammatory environment
release of free hemoglobin and heme secondary to RBC lysis
borderline activation of the coagulation system
abnormally exposed phosphatidylserine - at the SS-RBC surface
activated circulating endothelial cells – express tissue factor
Lead to the production of proinflammatory cytokines -> generalized cell activation.
PMNs
Platelets
Endothelial cells
48. Vasoconstriction
Regulation of the vascular tone balance
between
Vasoconstrictors - endothelin-1 (ET-1)
vasodilators - nitric oxide (NO)
In SCD NO level decrease due to free HB
Haemoglobin is the most powerful NO
scavenger known
destroys NO and generates free radicals
reduced NO production by depletion of endothelial
NO synthase
Balance shift towards vasoconstriction
49. Proposed model of sickle cell VOC
1. endothelial activation by SS-RBCs and other
inflammatory mediators
2. recruitment of adherent leukocytes
3. activation of recruited neutrophils and of other
leukocytes (eg, monocytes or NK cells)
4. interactions of sickle erythrocytes with adherent
neutrophils
5. vascular clogging by heterotypic cell-cell aggregates
composed of SS-RBCs, adherent leukocytes and
possibly platelets
6. increased transit time to greater than the delay time
for deoxygenation-induced hemoglobin
polymerization, propagating retrograde VOC
7. ischemia as a result of the obstruction that creates a
feedback loop of worsening endothelial activation
50. Summery
Red cell has unique structure and molecules for gas transportation
Pathogenesis of SCD involves complicated chemical pathways
Novel/Experimental drugs utilize the understanding of the complex pathogenesis of
sickle cell disease.
51. References
1. Pathophysiological insights in sickle cell disease; Marie-Hélène
Odièvre, Emmanuelle Verger, Ana Cristina Silva-Pinto,* and Jacques
Elion; Indian J Med Res. 2011 Oct; 134(4): 532–537.
2. Treating sickle cell disease by targeting HbS polymerization; William
A. Eaton, H. Franklin Bunn; Blood 2017 129: 2719-2726
3. Vaso-occlusion in sickle cell disease: pathophysiology and novel
targeted therapies; Deepa Manwani and Paul S. Frenette;
Blood 2013 122:3892-3898
4. Ganong’s review of physiology